We are presenting data highlighting the validity of SV95C on young DMD patients at poster P380. You can poster P380 on SV95C in young DMD patients here!
Feel free to reach out if you’d like to learn more about the results or if you want to understand how these data could support decision-making in your clinical program.
See you in Paris from 22nd to 25th April!
Can a single wearable platform derive meaningful clinical conclusions across 10+ neurological diseases? The evidence says yes.We’re presenting three new posters at EAN 2025, each
As the development of innovative therapies for ALS accelerates around the world, the need for objective and clinically meaningful measures of disease progression has never
We’re attending the 15th International Myotonic Dystrophy Consortium Meeting, taking place May 26–30, 2026 in Saguenay, Québec, Canada. This year, we’re presenting real-world data from
